Barclays raised the firm’s price target on Westlake to $160 from $142 and keeps an Equal Weight rating on the shares as part of a Q1 earnings preview for the chemicals and packaging group. A modest recovery emerging, but this is against valuations at multi-year highs, the analyst tells investors in a research note. The firm thinks the “early cycle playbook” continues to support the space but it “getting more selective” in its stock picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>